Ribitol treatment rescues dystroglycanopathy mice with common L276I mutation.
Matriglycan of alpha dystroglycan (α-DG) serves as a receptor for extracellular matrix proteins. Hypoglycosylation of α-DG underlies specific types of muscular dystrophy, dystroglycanopathy. Fukutin Related Protein (FKRP) gene encodes a glycosyltransferase that adds ribitol-5-phosphate to the core g...
Saved in:
| Main Authors: | Bo Wu, Pei Juan Lu, Morgan Drains, Sapana Shah, Anthony Blaeser, Victoria Leroy, Jessalyn Killilee, Molly Holbrook, Qi Long Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0325239 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Muscular Dystrophy-Dystroglycanopathy and Epilepsy
by: J Gordon Millichap
Published: (2013-01-01) -
UDP‐glucose dehydrogenase variants cause dystroglycanopathy
by: Anna M. Reelfs, et al.
Published: (2025-06-01) -
Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant mice
by: Marcela P. Cataldi, et al.
Published: (2025-01-01) -
Metabolic Engineering of Glycofusion Bispecific Antibodies for α-Dystroglycanopathies
by: Xiaotian Zhong, et al.
Published: (2024-10-01) -
Flow cytometry for the analysis of α-dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies.
by: Elizabeth Stevens, et al.
Published: (2013-01-01)